Skip to main content
Fig. 1 | EJNMMI Radiopharmacy and Chemistry

Fig. 1

From: Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies

Fig. 1

Chemical structure of the Lu-rhPSMA-10 isomers, differing in the stereoconfiguration of diaminopropionic acid (Dap) branching unit. D-Dap: rhPSMA-10.1 and L-Dap: rhPSMA-10.2. The PSMA inhibitor displays two moieties for radiolabeling: A silicon–fluoride acceptor (SiFA, colored in green), allowing 18F-labeling for PET, and a chelator (colored in orange) for complexation of radiometals

Back to article page